Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-11

Clinical Trial Update: Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated the efficacy of a sulfadoxine-pyrimethamine and artemisinin-containing combination therapy for uncomplicated malaria and has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemisinin-based combination therapy (artemisinin-based combination therapy)
  • Fansidar (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Malaria (Uncomplicated) | Phase 4 | Status: COMPLETED